-. Carb, Combating antibiotic-resistant bacteria, 2019.

E. Tacconelli, A. Peschel, and I. B. Autenrieth, Translational research strategy: an essential approach to fight the spread of antimicrobial resistance, J Antimicrob Chemother, vol.69, pp.2889-91, 2014.

, Comité interministériel pour la santé, Maîtriser la résistance bactérienne aux antibiotiques. Novembre, 2016.

V. A. Schweitzer, I. Van-heijl, C. H. Van-werkhoven, J. Islam, K. D. Hendriks-spoor et al., The quality of studies evaluating antimicrobial stewardship interventions: a systematic review

, Clin Microbiol Infect, vol.25, pp.555-61, 2019.

V. Donisi, M. Sibani, E. Carrara, D. Piccolo, L. Rimondini et al., Emotional, cognitive and social factors of antimicrobial prescribing: can antimicrobial stewardship intervention be effective without addressing psycho-social factors?, J Antimicrob Chemother, vol.74, issue.10, pp.2844-2851, 2019.

V. A. Schweitzer, C. H. Van-werkhoven, R. Baño, J. Bielicki, J. Harbarth et al.,

M. , Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group, Clin Microbiol Infect, 2019.

E. Tacconelli, M. A. Cataldo, M. Paul, L. Leibovici, J. Kluytmans et al., STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship, BMJ Open, vol.6, p.10134, 2016.

T. C. Hoffmann, P. P. Glasziou, I. Boutron, R. Milne, R. Perera et al., Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide, BMJ, vol.348, p.1687, 2014.

, Global coordination of antimibrobial resistance research and developpement, 2019.

, Joint Scientific Opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals, EFSA Journal, vol.15, issue.10, p.5017, 2017.

L. Watier, P. Cavalié, B. Coignard, and C. Brun-buisson, Comparing antibiotic consumption between two European countries: are packages an adequate surrogate for prescriptions?, Euro Surveill, vol.22, issue.46, 2017.

, World Health Organisation. AWaRe policy brief, 2019.

C. Vandenbroucke-grauls, G. Kahlmeter, and J. Kluytmans, Kluytmans-van den Bergh M

D. L. Monnet and G. S. Simonsen, The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance, BMJ Glob Health, vol.4, p.1838, 2019.

C. Oliveira-hashiguchi, T. , A. Ouakrim, D. Padget, M. Cassini et al., Resistance proportions for eight priority antibiotic-bacterium combinations in OECD, EU/EEA and G20 countries 2000 to 2030: a modelling study, Euro Surveill, issue.20, 2019.

A. Versporten, I. C. Gyssens, C. Pulcini, A. A. Monnier, J. Schouten et al.,

L. Maréchal, M. Tebano, G. Monnier, A. A. Adriaenssens, N. Gyssens et al.,

, Quality indicators assessing antibiotic use in the outpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.40-49, 2018.

A. A. Monnier, J. Schouten, L. Maréchal, M. Tebano, G. Pulcini et al.,

, Quality indicators for responsible antibiotic use in the inpatient setting: a systematic review followed by an international multidisciplinary consensus procedure, J Antimicrob Chemother, 2018.

S. Benic, M. Milanic, R. Monnier, A. A. Gyssens, I. C. Adriaenssens et al.,

, Metrics for quantifying antibiotic use in the hospital setting: results from a systematic review and international multidisciplinary consensus procedure, J Antimicrob Chemother, vol.73, issue.suppl_6, pp.50-58, 2018.

B. Rump, A. Timen, M. Verweij, and M. Hulscher, Experiences of carriers of multidrug-resistant organisms: a systematic review, Clin Microbiol Infect, vol.25, pp.274-283, 2019.

A. B. Drive and . Report, Revitalizing the antibiotic pipeline, 2018.

, World Health Organisation. IACG discussion paper. Antimicrobial resistance: invest in innovation and research, and boost R&D and access, 2018.

, group/IACG_AMR_Invest_innovation_research_boost_RD_and_access_110618.pdf

S. Lanini, J. Ioannidis, F. Vairo, M. Pletschette, G. Portella et al., Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials, Lancet Infect Dis, vol.pii, pp.30284-30285, 2019.

S. A. Kraemer, A. Ramachandran, and G. G. Perron, Antibiotic pollution in the environment: from microbial ecology to public policy. Microorganisms, vol.7, 2019.

F. Baquero, T. M. Coque, and F. De-la-cruz, Ecology and evolution as targets: the need for novel ecoevo drugs and strategies to fight antibiotic resistance, Antimicrob Agents Chemother, vol.55, p.3649, 2011.

M. Jacobs, N. Grégoire, W. Couet, and J. B. Bulitta, Distinguishing antimicrobial models with different resistance mechanisms via population pharmacodynamic modeling, PLoS Comput Biol, vol.12, p.1004782, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02141647

J. Berthuin, M. Miras, and F. Bpi, La résistance aux antibiotiques. Un enjeu de santé publique et économique, 2018.

. Folkhalsomyndigheten, Public Health Agency of Sweden. Availability of antibiotics, 2019.

, Department of Health and Social Care. UK government. Development of new antibiotics encouraged with new pharmaceutical payment system, Juillet, 2019.

. Combacte, CLIN-Net maintains an up-to-date portfolio of clinical trial sites across Europe. This maximizes the efficiency of site selection and study performance for studies related to antimicrobial resistance, 2019.

. Infectiologie and . Renarci, Réseau national de recherche clinique en infectiologie, 2019.

. Crics-triggersep, Clinical research in intensive care and sepsis. Trial group for global evaluation and research in sepsis. F-Crin network, 2019.